Skip to main content
Premium Trial:

Request an Annual Quote

'Genomic Anarchy'? We're In!

In his response to a recent Forbes article — which makes projections about the future of sequencing and profiles Ion Torrent's Jonathan Rothberg — Mike the Mad Biologist stresses that a "sequencing revolution" and a "genomics revolution" are not one and the same. Sequencing, he says, "is the easy part." Even assembly is no longer the strenuous task it once was. Annotation and analysis, however, are "not trivial in terms of computation." Mike says that although "high-throughput sequencing is an essential component," it cannot fuel the so-called genomics revolution alone. Looking forward, Mike expects standardization to be an obstacle for annotation. In fact, he predicts that without standardization of both raw genomic data and its associated metadata, "we won't have a genomic revolution, but genomic anarchy."

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.